Edition:
United States

People: AC Immune SA (ACIU.OQ)

ACIU.OQ on NASDAQ Stock Exchange Global Market

9.77USD
16 Nov 2018
Change (% chg)

$0.12 (+1.24%)
Prev Close
$9.65
Open
$9.64
Day's High
$9.83
Day's Low
$9.45
Volume
10,916
Avg. Vol
49,550
52-wk High
$17.39
52-wk Low
$7.21

Bohlen und Halbach, Friedrich von 

Mr. Friedrich von Bohlen und Halbach is Member of Board of Director at AC Immune Ltd October 2015. He is co-founder and managing director of dievini Hopp BioTech holding GmbH & Co. KG. He brings extensive industry experience from Fresenius AG, FAG Kugelfischer, and WASAG-Chemie AG, founded LION bioscience AG in 1997 (now SYGNIS Pharma AG) and served as the companys CEO. Dr. von Bohlen is a board member of various companies of the dievini portfolio and Chairman of Apogenix AG, CureVac AG and Novaliq GmbH. He holds a PhD in Neurobiology from the Swiss Federal Institute of Technology in Zurich, Switzerland.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --